Bioprocessing Market Outlook: 2025-2030 (5th Ed.)

Biologic therapies have quickly reshaped modern medicine, offering targeted, effective treatments for complex diseases, cancers, and autoimmune disorders. As their use expands across therapeutic areas, the biologics market continues its strong growth trajectory.

ISR’s Bioprocessing Market Outlook: 2025-2030 (5th Edition) provides an overview of the current market dynamics for bioprocessing as well as a prediction of what the marketplace will look like in five years. Key statistics include annual project volume, proportion outsourced, and number of CDMOs to complete the work; use rates of the main production systems, the proportion of marketed biologics based off each development platform, which platforms are more likely to be outsourced, and a breakdown of annual outsourced expenditure by platform.

The report also offers insight into the CDMO selection process, decision-making group, manufacturer selection criteria, and what drives sponsor satisfaction on outsourced bioprocessing projects. Contract manufacturers will get a view of the competitive landscape via sponsor awareness, consideration, use and preference rates for the 32 included CDMOs.

What you will learn:

Drug Developers:

• Gain insight into where the biologics industry is heading over the next five years with respect to protein expression systems utilized and types of biologics in development
• Understand the CDMO usage patterns of industry peers to identify whether additional outsourcing advantages can be obtained for your organization
• Learn the criteria used by peers to help scientifically and strategically evaluate CDMOs for bioprocessing projects

CDMOs:

• Pinpoint which CDMO attributes have led to successful outsourcing relationships, those that have caused service providers to lose bids and what truly drives sponsor satisfaction, then internally assess your company on these metrics
• Identify changes in demand for outsourced activities and services in order to prepare for future needs
• Better position your company to win business by understanding the dynamics of different buyer groups and developing targeted marketing to speak directly to their unique needs

Major Sections:

• Market Dynamics
• Service Provider Selection and Perceptions
• Trends, Predictions and Preferences
• Appendix

Respondents were required to pass several screening criteria to qualify and participate in this survey:

• Must work at a pharmaceutical or biotech company
• Must have responsibilities in the following categories: API souring/API management, CMC, Formulation/Pre-formulation, Executive management, Clinical trial manufacturing, Commercial manufacturing, Outsourcing/Purchasing management, Quality Assurance/Quality Control, Regulatory affairs, R&D management, or Supply chain
• Must have been involved in outsourced development or manufacturing of biologic-based therapeutic drugs within the past 18 months
• Must play a role in gathering information about service providers, selecting service providers and/or managing contract manufacturing activities